[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100066008":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":32,"centralContacts":11,"locations":37,"responsibleParty":70,"collaborators":11,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":11,"eligibilityCriteria":78,"healthyVolunteers":74,"sex":79,"minAge":80,"maxAge":11,"enrollmentInfo":81,"targetDuration":11,"studyType":84,"phases":85,"briefSummary":87,"conditions":88,"keywords":11,"overallStatus":90,"whyStopped":11,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":100},{"fullName":5,"class":6},"ZARS Pharma Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"S-Caine Peel","EXPERIMENTAL",null,[13],"Drug: S-Caine™ Peel (lidocaine and tetracaine cream 7%\u002F7%)",{"label":15,"type":16,"description":11,"interventionNames":17},"Placebo Peel","PLACEBO_COMPARATOR",[18],"Drug: Placebo Peel",[20,27],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","S-Caine™ Peel (lidocaine and tetracaine cream 7%\u002F7%)","S-Caine Peel was composed of a 1:1 eutectic mixture of 7% lidocaine and 7% tetracaine and was applied topically. S-Caine Peel was applied with a uniform thickness of approximately 1 mm and remained on the treatment area for 30 minutes (+\u002F- 2 minutes).",[9],[26],"Pliaglis",{"type":21,"name":15,"description":28,"armGroupLabels":29,"otherNames":30},"Placebo Peel applied topically with a uniform thickness of approximately 1 mm and remained on the treatment area for 30 minutes (+\u002F- 2 minutes).",[15],[31],"Placebo",[33],{"name":34,"affiliation":35,"role":36},"Michael Gold, MD","Tennessee Clinical Research Center","PRINCIPAL_INVESTIGATOR",[38,51,60],{"facility":39,"status":11,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":11},"AboutSkin Dermatology","Englewood","Colorado","80113","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-104.98776,39.64777,{"lat":49,"lon":48},{"facility":35,"status":11,"city":52,"state":53,"zip":54,"country":43,"countryCode":44,"cosmosGeoPoint":55,"geoPoint":59,"contacts":11},"Nashville","Tennessee","37215",{"type":46,"coordinates":56},[57,58],-86.78444,36.16589,{"lat":58,"lon":57},{"facility":61,"status":11,"city":62,"state":63,"zip":64,"country":43,"countryCode":44,"cosmosGeoPoint":65,"geoPoint":69,"contacts":11},"J&S Studies, Inc.","Bryan","Texas","77802",{"type":46,"coordinates":66},[67,68],-96.36996,30.67436,{"lat":68,"lon":67},{"type":71,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100066008","phase-3-s-caine-peel-skin-numbing-cream-to-treat-pain-during-skin-filler-injection-in-the-face-100066008",false,"NCT00110760","S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Skin Filler Injection in the Face","Randomized, Double-Blind, Placebo Controlled, Paired Study Evaluating S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream)for Induction of Local Dermal Anesthesia for Dermal Filler Injection on the Face of Adults","Inclusion Criteria:\n\n* Patient is 18 years of age or older\n* Patient elects to undergo dermal filler injection in the face\n\nExclusion Criteria:\n\n* Patient is pregnant or breastfeeding\n* Patient has participated in a clinical trial of an unapproved drug within the previous 30 days\n* Patient has participated in any previous clinical trial involving S-Caine Peel","ALL","18 Years",{"count":82,"type":83},70,"ACTUAL","INTERVENTIONAL",[86],"PHASE3","Injection of dermal filler is used as an aesthetic treatment to fill in unwanted wrinkles and scars. There can be substantial pain associated with dermal filler injections. For this reason, local anesthesia is often used to eliminate or minimize the pain. This anesthesia can be administered by injection or through the use of topical creams and ointments.\n\nS-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) is a eutectic formulation of lidocaine and tetracaine. The purpose of this study is to evaluate if S-Caine Peel is effective in providing topical local dermal anesthesia for dermal filler injections in adults.",[89],"Pain","COMPLETED","2012-06-04",{"date":93,"type":94},"2012-06-05","ESTIMATED",{"date":96,"type":11},"2005-06",{"date":98,"type":83},"2005-09",{"name":5,"class":6},3]